0 Ratings
ID

42584

Description

Omega-3 Fatty Acids Efficacy in First-episode of Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT02210962

Link

https://clinicaltrials.gov/show/NCT02210962

Keywords

Versions (1)
  1. 9/15/21 9/15/21 -
Copyright Holder

Medical University of Lodz

Uploaded on

September 15, 2021

DOI

To request one please log in.

License

Creative Commons BY-NC 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Schizophrenia NCT02210962

    English

    Eligibility Schizophrenia NCT02210962

    1 forms  
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    patients diagnosed with schizophrenia using diagnostic and statistical manual of mental disorders, fourth edition (dsm-iv) criteria
    Description

    Schizophrenia, DSM-IV criteria

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0036341
    UMLS CUI [1,2]
    C0220952
    patients aged between 16-35 years
    Description

    Age

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    signed informed consent (parallel parents consent for individuals under 18 years of age)
    Description

    Informed consent | Parents consent for for individuals under 18 years of age

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    UMLS CUI [2,1]
    C0021430
    UMLS CUI [2,2]
    C0030551
    UMLS CUI [2,3]
    C0026193
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    patients taking fish oil supplements (a washout period of 6 months is required)
    Description

    Fish oil supplements (a washout period is required)

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0016157
    UMLS CUI [1,2]
    C0242295
    UMLS CUI [1,3]
    C1710661
    UMLS CUI [1,4]
    C1514873
    patients diagnosed with epilepsy or suffering from epileptic seizures
    Description

    Epilepsy | Epileptic seizures

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0014544
    UMLS CUI [2]
    C4317109
    patients receiving anticoagulant medication e.g., warfarin
    Description

    Anticoagulant therapy

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0150457
    patients receiving psychotherapy
    Description

    Psychotherapy

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0033968
    chronic somatic diseases
    Description

    Chronic somatic diseases

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0008679
    UMLS CUI [1,2]
    C2986476
    psychoactive substance dependence
    Description

    Psychoactive substance dependence

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0038580
    UMLS CUI [1,2]
    C0682880
    pregnancy and lactation
    Description

    Pregnancy | Breast Feeding

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0006147
    mental retardation or diagnosed organic brain injury
    Description

    Mental retardation | Brain injury

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0025362
    UMLS CUI [2]
    C0270611
    Back to the top of the page

    Similar models

    Eligibility Schizophrenia NCT02210962

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Schizophrenia, DSM-IV criteria
    Item
    patients diagnosed with schizophrenia using diagnostic and statistical manual of mental disorders, fourth edition (dsm-iv) criteria
    boolean
    C0036341 (UMLS CUI [1,1])
    C0220952 (UMLS CUI [1,2])
    Age
    Item
    patients aged between 16-35 years
    boolean
    C0001779 (UMLS CUI [1])
    Informed consent | Parents consent for for individuals under 18 years of age
    Item
    signed informed consent (parallel parents consent for individuals under 18 years of age)
    boolean
    C0021430 (UMLS CUI [1])
    C0021430 (UMLS CUI [2,1])
    C0030551 (UMLS CUI [2,2])
    C0026193 (UMLS CUI [2,3])
    Item Group
    C0680251 (UMLS CUI)
    Fish oil supplements (a washout period is required)
    Item
    patients taking fish oil supplements (a washout period of 6 months is required)
    boolean
    C0016157 (UMLS CUI [1,1])
    C0242295 (UMLS CUI [1,2])
    C1710661 (UMLS CUI [1,3])
    C1514873 (UMLS CUI [1,4])
    Epilepsy | Epileptic seizures
    Item
    patients diagnosed with epilepsy or suffering from epileptic seizures
    boolean
    C0014544 (UMLS CUI [1])
    C4317109 (UMLS CUI [2])
    Anticoagulant therapy
    Item
    patients receiving anticoagulant medication e.g., warfarin
    boolean
    C0150457 (UMLS CUI [1])
    Psychotherapy
    Item
    patients receiving psychotherapy
    boolean
    C0033968 (UMLS CUI [1])
    Chronic somatic diseases
    Item
    chronic somatic diseases
    boolean
    C0008679 (UMLS CUI [1,1])
    C2986476 (UMLS CUI [1,2])
    Psychoactive substance dependence
    Item
    psychoactive substance dependence
    boolean
    C0038580 (UMLS CUI [1,1])
    C0682880 (UMLS CUI [1,2])
    Pregnancy | Breast Feeding
    Item
    pregnancy and lactation
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    Mental retardation | Brain injury
    Item
    mental retardation or diagnosed organic brain injury
    boolean
    C0025362 (UMLS CUI [1])
    C0270611 (UMLS CUI [2])
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial